RICCIOTTI, ILARIA
 Distribuzione geografica
Continente #
AS - Asia 223
EU - Europa 110
NA - Nord America 109
SA - Sud America 12
AF - Africa 5
Totale 459
Nazione #
US - Stati Uniti d'America 107
CN - Cina 83
SG - Singapore 64
IT - Italia 47
VN - Vietnam 35
NL - Olanda 23
HK - Hong Kong 16
DE - Germania 11
IN - India 11
BR - Brasile 10
KR - Corea 10
FI - Finlandia 7
FR - Francia 6
GB - Regno Unito 5
CH - Svizzera 3
RU - Federazione Russa 3
CI - Costa d'Avorio 2
JP - Giappone 2
KE - Kenya 2
AR - Argentina 1
AT - Austria 1
BA - Bosnia-Erzegovina 1
CA - Canada 1
EC - Ecuador 1
EE - Estonia 1
GR - Grecia 1
IE - Irlanda 1
IL - Israele 1
IQ - Iraq 1
MX - Messico 1
SC - Seychelles 1
Totale 459
Città #
Singapore 43
Hefei 33
Dallas 29
Ashburn 28
Bologna 16
Hong Kong 15
Ho Chi Minh City 12
Hanoi 11
Beijing 10
Santa Clara 10
Seoul 10
Los Angeles 7
Milan 6
Boardman 4
Munich 4
Visakhapatnam 4
Bengaluru 3
Buffalo 3
Helsinki 3
Luco dei Marsi 3
Modena 3
Mumbai 3
New York 3
Shanghai 3
Turku 3
Abidjan 2
Amsterdam 2
Changsha 2
Chongqing 2
Denver 2
Falkenstein 2
Frankfurt am Main 2
Novara 2
Pescara 2
Poplar 2
Qingdao 2
Redondo Beach 2
Rio de Janeiro 2
Salerno 2
Tokyo 2
Zurich 2
Almenno San Bartolomeo 1
Barbacena 1
Biên Hòa 1
Boston 1
Boydton 1
Bình An 1
Bắc Ninh 1
Campinas 1
Caçapava 1
Cesena 1
Changchun 1
Chaohu 1
Córdoba 1
Da Nang 1
Dublin 1
Elk Grove Village 1
Erba 1
Florianópolis 1
Gravataí 1
Greenwich 1
Guayaquil 1
Ha Long 1
Haiphong 1
Hyderabad 1
Jacarezinho 1
Jaguarão 1
Kai Yi Wan 1
Kampong Loyang 1
Kunming 1
Lappeenranta 1
Manchester 1
Maysan 1
Montreal 1
Moscow 1
Nairobi 1
Nanjing 1
Nanyang 1
Nuremberg 1
Paracatu 1
Querétaro 1
Quảng Ninh 1
Rancho Palos Verdes 1
Rende 1
San Francisco 1
Sangerhausen 1
Sarajevo 1
Seattle 1
Tallinn 1
Tam Bình 1
Tel Aviv 1
Thessaloniki 1
Thái Nguyên 1
Vũng Tàu 1
Weifang 1
Wenzhou 1
Wuhan 1
Wuxi 1
Xuzhou 1
Yubileyny 1
Totale 360
Nome #
STK11 mutations correlate with poor prognosis for advanced NSCLC treated with first-line immunotherapy or chemo-immunotherapy according to KRAS, TP53, KEAP1, and SMARCA4 status 132
Development and validation of a new tool to estimate early mortality in patients with advanced cancer treated with immunotherapy 110
Early monitoring of plasma KRAS G12C with digital PCR predicts antitumor response to immunotherapy or sotorasib in advanced NSCLC: A brief report 91
Resistance to KRAS G12C Inhibition in Non-small Cell Lung Cancer 73
Non-small cell lung cancer: an update on emerging EGFR-targeted therapies 63
Totale 469
Categoria #
all - tutte 1.150
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.150


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20247 0 0 0 0 0 0 0 1 2 0 0 4
2024/2025204 1 8 5 10 22 9 22 18 6 32 28 43
2025/2026258 57 61 51 53 28 8 0 0 0 0 0 0
Totale 469